Akari Therapeutics (NASDAQ:AKTX)

Akari Therapeutics (NASDAQ:AKTX)


Share Price
$ 1.92
Change
-0.33 (-14.67 %)
Market Cap
$31.69 m
Proactive Investors - Run By Investors For Investors

Akari Therapeutics

We are developing life-transforming treatments for autoinflammatory diseases involving the complement (C5) and leukotriene (LTB4) pathways.

EPIC: AKTX
Market: NASDAQ:AKTX
52-week High/Low: $9.190 / $1.560
Sector: Pharmaceuticals
Market Cap: $31.69 m
Website: www.akaritx.com
col 3
col 4
col 5
col 6

Akari Therapeutics Timeline

Video RSS

Videos

VIEW ALL VIDEOS

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use